Search Results 81-90 of 16669 for Progressive supranuclear palsy
Mayo Clinic researchers are working to improve diagnosis and treatment of progressive supranuclear palsy. Specialists trained in movement disorders conduct ...
The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
The purpose of this study is to determine objective measures of gait and balance impairment in PSP syndromes using laboratory-based motion analysis.
Progressive supranuclear palsy (PSP) is a rapidly progressive neurodegenerative disorder with clinicopathologic heterogeneity and without any therapies.
Progressive supranuclear palsy is a rapidly progressive neurodegenerative disorder with clinicopathologic heterogeneity and without any therapies.
... Progressive Supranuclear Palsy (PSP) Rating Scale (PSPRS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.